A positive surprise is on the way: Stoke Therapeutics Inc (STOK) Stock

TD Cowen raised the price target for the Stoke Therapeutics Inc (NASDAQ:STOK) stock from “a Market perform” to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The stock was upgraded by BofA Securities, who disclosed in a research note on May 01, 2023, from Underperform to Neutral and set the […]

Nurix Therapeutics Inc (NRIX) Stock offers help to cash-strapped investors

Oppenheimer raised the price target for the Nurix Therapeutics Inc (NASDAQ:NRIX) stock to “an Outperform”. The rating was released on June 26, 2023, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $25. The stock was initiated by Morgan Stanley, who disclosed in a […]

Lindblad Expeditions Holdings Inc (LIND) Stock is looking to regain its victory

B. Riley Securities raised the price target for the Lindblad Expeditions Holdings Inc (NASDAQ:LIND) stock to “a Buy”. The rating was released on November 10, 2023, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $20. In their research brief published July 23, 2021, […]

A leader in the success game: Inhibrx Biosciences Inc. (INBX) Stock

The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated -6.41% within the last five trades and 1.80% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price decreased -54.19% in the last 6 months […]

The idea of catching Mullen Automotive Inc (MULN) Stock might be a good one

The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated -10.45% within the last five trades and -36.84% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price decreased -78.18% in the last 6 months […]

It’s not the right time to quit: Humacyte Inc (HUMA) Stock

H.C. Wainwright raised the price target for the Humacyte Inc (NASDAQ:HUMA) stock to “a Buy”. The rating was released on December 11, 2023, according to finviz. We previously noted in another research note published on August 14, 2023 by Piper Sandler that upgraded the stock from an Underweight to a Neutral with a price target […]

Top-line Growth is Likely to Be Driven by Sight Sciences Inc (SGHT) Stock

William Blair raised the price target for the Sight Sciences Inc (NASDAQ:SGHT) stock from “an Outperform” to “a Mkt perform”. The rating was released on September 12, 2023, according to finviz. We previously noted in another research note published on September 12, 2023 by Piper Sandler that downgraded the stock from an Overweight to a […]